News

Public · Published

USO, UCO Slide As Brent Retreats On US-Iran De-escalation Hopes – But Goldman Reportedly Sees Oil At $105 In December

Oil prices and oil-linked exchange-traded funds fell as crude futures dropped more than 3% on Monday amid continuing US-Iran negotiations. Goldman Sachs reportedly raised its December Brent crude forecast to $105 a barrel, while concerns about possible Middle East supply disruptions continued to support higher bank forecasts.

Published:

Updated:

What happened

Oil prices and oil-linked exchange-traded funds fell as crude futures dropped more than 3% on Monday amid continuing US-Iran negotiations. Goldman Sachs reportedly raised its December Brent crude forecast to $105 a barrel, while concerns about possible Middle East supply disruptions continued to support higher bank forecasts.

Confirmed

Global impact / market context

The article describes two opposing forces: hopes for diplomacy can reduce concern about disrupted oil supplies and weigh on crude prices, while supply fears can support forecasts. Lower oil prices can reduce revenue for producers and the value of oil-linked funds, while higher forecasts signal continuing uncertainty.

Analyst inference

The supplied article reports falling crude prices alongside Goldman Sachs’s higher December Brent forecast of $105 a barrel. That contrast reflects uncertainty rather than a settled direction: negotiations encouraged hopes of de-escalation, while concerns about Middle East supply disruptions remained a counterweight.

Confirmed

What to watch

  1. Watch for further US-Iran negotiations and statements on a diplomatic resolution; signs of progress could ease supply-disruption concerns and add pressure to crude prices. Analyst inference
  2. Watch whether Goldman Sachs maintains or changes its reported December Brent forecast of $105 a barrel as developments affect its view of supply risks. Analyst inference
  3. Watch for changes in crude futures and oil-linked exchange-traded funds; the article says both fell amid negotiations, but gives no specific prices or fund names. Confirmed

Evidence